PMC4019786_01
PMC4019786_02
Activity of Trabectedin in DSRCT. Reduction in size of a nodule deep to the xiphisternum (A and B) and significant reduction of the omental disease (C and D) after three cycles of Trabectedin in case 2.
2045-3329-4-3-1.jpg
PMC4019786_02_2045-3329-4-3-1.jpg
F1
A restaging assessment performed in November 2012 after 3 cycles of Trabectedin showed a reduction in size of the nodule deep to the xiphisternum (5 x 2.5 cm) and a significant reduction of the omental disease associated with minimal free fluid in the abdomen and pelvis (Figure 1).